Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

Go back to Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

Moderna (MRNA) Declines 7% Pre-Open Following Interim Phase 1 Data for mRNA Flu Vaccine and Program Update

December 10, 2021 7:13 AM EST

Moderna (NASDAQ: MRNA) Declines 7% Pre-Open Following Interim Phase 1 Data for mRNA Flu Vaccine and Program Update

... More